NRAS and neoplasm: Chung and colleagues found increased adenoma-to-carcinoma conversion with SHH transgene-induced injury [72], while Dauch and colleagues found that CCl4 could overcome NRas-induced p19Arf tumor suppressor activity, to increase tumor burden [26].